company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2012.0,Q3,2012-07-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3655000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3655000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,350000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-12000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,212000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2477000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-628000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-628000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-50000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-9991000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,18000000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2012.0,Q3,2012-07-01,2012-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,7959000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,7959000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-144000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-123000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,146000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-121000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-121000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2012.0,Q3,2012-07-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,7210000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4295000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4295000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,352000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-45000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,217000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4988000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8759000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8759000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-54000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-39969000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,45000000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2012.0,Q4,2012-10-01,2012-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,4977000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,4977000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,10000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,10000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,10000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2012.0,Q4,2012-10-01,2012-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3772000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:08:16+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8598000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:08:16+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8598000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:08:16+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,350000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:08:16+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-10000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:08:16+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,205000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:08:16+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2097000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:08:16+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5956000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:08:16+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5956000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:08:16+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-78000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:08:16+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-10292000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:08:16+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,10000000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:08:16+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-370000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:08:16+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-370000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:08:16+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-6326000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9644000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9644000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,351000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-17000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,432000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,5140000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-3738000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-3738000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-45000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-14998000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,25000000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q2,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,9957000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,9957000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,17000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,17000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,17000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q2,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,6236000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q3,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3485000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3485000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,346000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-16000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,627000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-10533000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-13061000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-13061000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-30000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-102244000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,25000000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q3,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-77274000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-77274000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,85155000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,99000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,85254000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,85254000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q3,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5081000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4344000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4344000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,331000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,43000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,769000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,170550000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,167349000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,167349000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-404000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-5003000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,15250000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q4,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,9843000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,9843000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,20513000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,134000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,20647000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,20647000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q4,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,197839000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:47:55+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13871000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:47:55+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13871000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:47:55+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,328000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:47:55+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-23000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:47:55+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,651000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:47:55+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-19652000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:47:55+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-32567000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:47:55+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-32567000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:47:55+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-610000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:47:55+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-252991000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:47:55+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,102272000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:47:55+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-151329000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:47:55+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-151329000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:47:55+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,915000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:47:55+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,915000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:47:55+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,915000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:47:55+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-182981000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15597000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15597000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,357000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,52000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1609000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3966000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-17605000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-17605000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-537000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-29984000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,44999000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,14478000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,14478000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,556000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,556000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,556000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2571000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5486000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5486000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,370000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-20000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1875000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-15670000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-18871000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-18871000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-169000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-128902000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,154000000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,24929000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,24929000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,558000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,558000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,558000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,6616000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15056000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15056000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,375000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-9000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1946000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2710000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-15454000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-15454000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-493000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-24979000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,30000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,38986000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,13544000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,13544000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,53000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,53000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,53000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1857000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q4,2014-10-01,2014-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,8200000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:34:24+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14529000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:34:24+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14529000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:34:24+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,383000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:34:24+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2387000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:34:24+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-7857000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:34:24+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-19616000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:34:24+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-19616000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:34:24+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-398000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:34:24+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-9992000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:34:24+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,29979000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:34:24+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,19589000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:34:24+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,19589000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:34:24+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1004000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:34:24+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1004000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:34:24+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1004000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:34:24+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,977000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-21620000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-21620000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,407000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2417000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,6425000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12371000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12371000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-637000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-19987000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,39977000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,19353000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,19353000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,158000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,158000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,158000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,7140000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-24480000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-24480000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,426000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2511000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3879000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-25422000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-25422000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-143000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-88841000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,108909000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,19925000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,19925000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,522000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,522000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,522000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4975000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-24778000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-24778000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,427000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3451000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3171000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-17729000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-17729000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-186000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-9986000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,34971000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,24799000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,24799000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,94000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,94000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,94000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,7164000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:44:02+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-27213000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:44:02+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-27213000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:44:02+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,434000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:44:02+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2995000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:44:02+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,59669000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:44:02+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,35885000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:44:02+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,35885000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:44:02+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-516000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:44:02+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-30000000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:44:02+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,40010000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:44:02+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,9494000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:44:02+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,9494000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:44:02+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,740000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:44:02+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,740000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:44:02+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,740000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:44:02+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,46119000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-27689000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-27689000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,446000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2952000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1490000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-22801000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-22801000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-182000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-99635000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,74846000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-24971000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-24971000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,934000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,46000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,980000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,980000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-46792000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-25862000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-25862000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,448000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2828000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4585000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-27171000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-27171000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-160000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-77647000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,33926000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-43881000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-43881000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,62975000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,390000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,63365000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,63365000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-7687000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:16:24+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22608000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:16:24+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22608000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:16:24+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,428000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:16:24+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3123000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:16:24+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-9921000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:16:24+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-28978000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:16:24+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-28978000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:16:24+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-400000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:16:24+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-9967000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:16:24+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,39854000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:16:24+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,29487000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:16:24+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,29487000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:16:24+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1733000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:16:24+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1733000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:16:24+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1733000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:16:24+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2242000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15225000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15225000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,433000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2202000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-14522000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-27112000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-27112000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-64000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-27884000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,47800000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,19852000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,19852000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,5000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,5000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-7255000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10692000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10692000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,425000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1953000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-8217000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-16531000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-16531000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-20000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-69651000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,69673000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,2000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,2000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,466000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,466000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,466000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-16063000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,9463000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,9463000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,424000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2136000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-24372000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12349000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12349000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-101000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-19874000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,27884000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,7909000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,7909000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1840000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1840000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1840000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2600000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:16:24+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5574000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:16:24+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5574000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:16:24+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,423000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:16:24+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2278000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:16:24+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-11529000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:16:24+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-14402000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:16:24+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-14402000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:16:24+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-172000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:16:24+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-54270000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:16:24+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,69651000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:16:24+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,15209000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:16:24+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,15209000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:16:24+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,41000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:16:24+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,41000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:16:24+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,41000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:16:24+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,848000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3976000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3976000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,430000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1832000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6522000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8236000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8236000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-111000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-15092000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,19874000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,4671000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,4671000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3564000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,6115000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6115000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,435000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1592000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-16997000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8855000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8813000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-239000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-8017000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,14867000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,6611000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,6611000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,47000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,47000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,47000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2155000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4666000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4666000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,403000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1140000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-10246000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-13369000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-13411000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-133000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-4926000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,19750000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,14691000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,14691000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1280000.0
